How much funding has Inofab raised?

Inofab has raised $1.0M in total funding, most recently a Seed round.

Who are Inofab's investors?

Inofab's investors include F+ Ventures.

Where is Inofab headquartered?

Inofab is headquartered in Ankara, Turkey.

What industry is Inofab in?

Inofab operates in Healthcare, Digital Health, Medical Devices.

Inofab

Acquired

Digital respiratory care for home and clinic

Ankara, Turkey · Founded 2014 · $1.0M raised

Healthcare

Digital Health

Medical Devices

Headquarters: Ankara
Employees: 11–50
Founded: 2014
Business Model: B2B2C

Website: www.spirohome.io
Total Funding: $1.0M
Last Round: $1.0M SeedJan 2021
Rounds: 1

About

Inofab Health (now a Clario company) develops digital respiratory care technology including ultrasonic spirometers, smart inhalers, and the SpiroCloud disease management platform. Its products — SpiroHome Personal, SpiroClinic Pro, and SpiroHaler — help patients and clinicians manage chronic conditions like asthma, COPD, and cystic fibrosis at home and in clinical settings.

Summary

Inofab is a Healthcare company based in Ankara, Turkey, founded in 2014. It has raised $1.0M in total across 1 round, most recently a $1.0M Seed round in Jan 2021. Investors include F+ Ventures.

LinkedIn X (Twitter)